Acute effects of TTFCA on capillary filtration in severe venous hypertension.
The acute variation in capillary filtration [CF] was evaluated with strain-gauge plethysmography in patients with severe venous hypertension due to deep venous disease. Two groups were selected and randomly treated with a single oral dose or TTFCA (60 mg or 120 mg). CF was assessed again after 5 and 10 hours. Eleven patients were randomised in the 60 mg group and 9 in the 120 mg group. Also 5 normal subjects were studied with the same procedure to act as controls. No variations in CF were observed in normal limbs. In both groups of patients there was a significant decrease in CF after 5 and 10 hours. The percent decrease in CF after 10 hours was higher in the high dose group. These results indicate that TTFCA is acutely effective in reducing CF and oedema in subjects with venous hypertensive microangiopathy. The effects of TTFCA on CF appear to be dose related.
De Sanctis
M T
MT
Cardiovascular Institute, University of Chieti, Italy.
Incandela
L
L
Cesarone
M R
MR
Grimaldi
R
R
Belcaro
G
G
Marelli
C
C
D000328:Adult; D002199:Capillary Permeability / Q000187:drug effects*; D004305:Dose-Response Relationship, Drug; D004487:Edema / Q000503:physiopathology; D005260:Female; D006801:Humans; D008297:Male; D010991:Plethysmography; D013997:Time Factors; D014315:Triterpenes / Q000008:administration & dosage / Q000494:pharmacology*; D014689:Venous Insufficiency / Q000503:physiopathology*; D014690:Venous Pressure / Q000502:physiology*
C005084:TECA; D014315:Triterpenes